Solutions 30 : Annual General Meeting / Extraordinary General Meeting : Approval of all resolutions
ANNUAL GENERAL MEETING
EXTRAORDINARY GENERAL MEETING
Approval of all resolutions
SOLUTIONS 30 SE annual and extraordinary general meetings were held today. Considering the outbreak of the COVID-19 pandemic and the restrictions on travels and gatherings, these general meetings were held without a physical presence, as permitted by Luxembourg law.
155 shareholders were represented, holding a total of 65,505,714 shares, i.e. 61.15% of the share capital and voting rights.
All the resolutions were duly passed and the detailed vote results are available on SOLUTIONS 30 SE web site.
The 2019 financial statements were approved, as well as the remuneration report on the compensation awarded to the members of the Supervisory Board and Management Board for the 2019 financial year, the remuneration policy applicable to the members of the Supervisory Board and Management Board and the long-term incentive plan, three items which were submitted to an advisory vote of the shareholders for the first time.
The extraordinary general meeting held before notary public has approved the company’s articles of association, which were revamped in order to introduce the necessary provisions to proceed with the transfer of SOLUTIONS 30 SE shares from Euronext Growth to the regulated market of Euronext Paris.
A propos de Solutions 30 SE
Le Groupe Solutions 30 est le leader européen des solutions pour les Nouvelles Technologies. Sa mission est de rendre accessibles à tous, particuliers et entreprises, les mutations technologiques qui transforment notre vie quotidienne : hier l’informatique et Internet, aujourd’hui le numérique, demain les technologies qui rendront le monde toujours plus interconnecté en temps réel. Avec 30 millions d’interventions réalisées depuis sa création et un réseau de plus de 10 000 techniciens de proximité, Solutions 30 couvre actuellement la totalité de la France, l’Italie, l’Allemagne, les Pays-Bas, la Belgique, le Luxembourg, la Péninsule Ibérique et la Pologne. Le capital de Solutions 30 S.E. est composé de 107 127 984 actions, identiques au nombre de droits de vote théoriques et exerçables.
Solutions 30 S.E. est cotée sur Euronext Growth (ISIN FR0013379484- code ALS30) ainsi qu’à la Bourse de Francfort sur le système de cotation électronique XETRA (FR0013379484 – code 30L3). Indices : MSCI Europe Small Cap | Tech40 | CAC PME. Pour plus d’informations, vous pouvez consulter le site www.solutions30.com
Contact
Analystes/investisseurs : Nathalie Boumendil | Tél : +33 (0)6 85 82 41 95 | nathalie.boumendil@solutions30.com
Presse : Samuel Beaupain | Tél : + 352 2 777 4210 | media.relations@solutions30.com
Attachment
About GlobeNewswire
GlobeNewswireGlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
AND (Ticker: AND.AS) intends to rebrand the company22.9.2020 18:05:00 CEST | Press release
Supporting the turnaround and the new strategic direction of the company Capelle aan den IJssel, the Netherlands, 22 September 2020 - AND is happy to announce that it intends to change the company name and refresh its branding in Q4 2020. This change is designed to highlight the company’s new strategic direction as well as support and strengthen the transformation into a subscription based provider of premium location aware content and services. As announced on August 12th, the turnaround strategy has already delivered 22% revenue growth in the first half of 2020. AND believes the new company name and branding will help to drive continued revenue growth and put location-intelligence squarely at the center of the company’s profile. Further announcements will follow in Q4 2020. Ends About AND AND is an innovative location-aware content and service provider. Our focus is to create and deliver market leading, relevant, innovative and tailored content which fosters a safer and more sustaina
Wolters Kluwer Completes Divestment of ComplyTrack22.9.2020 17:30:00 CEST | Press release
Wolters Kluwer Completes Divestment of ComplyTrack September 22, 2020 - Wolters Kluwer announces today that it has completed the divestment of ComplyTrack to symplr, as originally announced on September 8, 2020. About Wolters Kluwer Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services. Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolt
Joint Stock Company “Olainfarm” Extraordinary Shareholders Meeting on September 22, 2020 at 15.00 has not been held due to lack of quorum22.9.2020 14:20:00 CEST | Press release
Joint Stock Company “Olainfarm” Extraordinary Shareholders Meeting on September 22, 2020 at 15.00 has not been held due to lack of quorum Joint Stock Company “Olainfarm” Management Board informs that for the Extraordinary Shareholders Meeting on September 22, 2020 at 15.00 pm shareholders who in total represented 3 877 425 voting shares or 27.53% of voting capital were registered, therefore shareholders' meeting did not take place due to lack of quorum. Olaine, September 22, 2020 Additional information: Jānis Dubrovskis Investor Relations Advisor of JSC Olainfarm Ph.: +371 29178878 janis.dubrovskis@olainfarm.com
RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 202022.9.2020 13:05:00 CEST | Press release
RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020 Report of the Board on results of operations in 2019. Resolution: To take notice of the Report of the Board of the JSC “Olainfarm” on results of operations in 2019. Voting results: decision is taken with the required majority of votes. Report of the Council on results of operations in 2019. Resolution: To take notice of the Report of the Council of the JSC “Olainfarm” on results of operations in 2019. Voting results: decision is taken with the required majority of votes. Approval of the JSC “Olainfarm” Consolidated Annual Report for 2019. Resolution: To approve the Consolidated and Parent Company’s Annual Report of JSC „Olainfarm” for 2019 with profit in amount of EUR 22 239 000,00. Voting results: decision is taken with the required majority of votes. Distribution of profit of 2019. Resolution: 4.1. To pay dividends to the shareholders of the Joint Stock Company" Olainfarm " i
ProMIS Neurosciences to develop multivalent vaccine for Alzheimer’s disease22.9.2020 12:30:10 CEST | Press release
Potential vaccine to incorporate ProMIS proprietary peptide antigens; early in vivo preclinical data demonstrate neuronal protection and improvement in cognitive deficits TORONTO and CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today initiation of a program to construct and test a multivalent peptide vaccine for Alzheimer’s disease (AD). The critical first steps in vaccine development will be carried out by VIDO-InterVac, a global leader in vaccine research and development. Recent progress in the development of blood-based biomarkers for neurodegeneration is enabling increased screening to diagnose and identify individuals at risk of developing AD. A vaccine capable of inducing an effective antibody response against amyloid-beta toxic oligom
AIR Worldwide Releases Updated Multiple Peril Crop Insurance Model for China22.9.2020 12:11:10 CEST | Press release
Boston, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Catastrophe risk modeling firm AIR Worldwide (AIR) today announced that it released an updated Multiple Peril Crop Insurance (MPCI) Model for China to support probabilistic assessments for five newly modeled crop lines of business and a newly modeled sub-peril. This update also includes a new livestock module that adds six additional lines of business and two new sub-perils. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “In 2011, AIR leveraged its considerable experience and success in modeling MPCI portfolios in the United States to develop a model for mainland China. Since then, the model has been updated several times to keep it current with the fast-changing Chinese agricultural insurance market,” said Dr. Jeff Amthor, assistant vice president, AIR Worldwide. “The MPCI Model for China captures the severity, frequency, and location of drought, flood, wind, frost, and heat events nationwide, covering over 90% of the weather-related crop